Ariane van der Straten
Director, Women’s Global Health Imperative
Ariane van der Straten, PhD, is a senior research scientist and expert in female-initiated HIV-prevention methods. Dr. van der Straten conducts biomedical and behavioral research for prevention of heterosexual transmission of HIV, with a focus on female-initiated methods, microbicides, and multipurpose prevention technologies.
She has led or participated in the development and implementation of major research projects in Africa and the U.S., including Phase I to Phase III trials of the diaphragm and gel, oral and vagina Tenofovir-based pre-exposure prophylaxis, and the vaginal ring. She has also led several studies focusing on adherence-related issues in the context of prevention trials, using quantitative and qualitative research methods.
Her recent research focuses on new tools and technologies to improve adherence and its measurement in biomedical prevention trials, and innovative approaches to monitor product use. Most recently, she was awarded a large multidisciplinary project to develop and test the use of a long-lasting, injectable, biodegradable, HIV-prevention device.
Additionally, Dr. van der Straten is an associate professor at the University of California, San Francisco.
MPH, Public Health, The Johns Hopkins University, School of Hygiene and Public Health; PhD, Zoology (summa cum laude), University of Brussels, Laboratory of Genetics; BS (summa cum laude), Zoology-Molecular Biology, University of Louvain, Belgium.
- Female-Initiated HIV Prevention Methods: Microbicides, Barrier Methods, and PrEP
- Acceptability, Adherence, and Their Measurement
- Clinical Trials
- Qualitative and Quantitative Research Methods
- December 17, 2013
RTI International, partners to develop and test the use of a long-lasting injectable biodegradable HIV prevention device
– News Release